metabolic
Exenatide
Synthetic exendin-4 GLP-1 agonist
0 vendors tracked0 live pricesLast crawl: 2026-06-09 18:02 UTC
About
A synthetic version of the Gila monster venom peptide exendin-4. First GLP-1 receptor agonist approved clinically for type-2 diabetes.
Also known as: Byetta (trade), Bydureon (trade)
Reconstitution calculator
!
For research purposes only. Not for human consumption. Always verify calculations independently.
Cost-per-dose recalculates as you adjust the calculator above.
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.
Keep exploring
More on Exenatide & related research
Related peptides
- Liraglutide— Daily GLP-1 receptor agonist
- Semaglutide— GLP-1 agonist for metabolic research
- Tirzepatide— Dual GLP-1/GIP agonist
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- Mazdutide— GLP-1/glucagon dual agonist